A	B	C	D	E	F	G	H	I	J	K	L	M	N
1	Main
2			6/30/2020	9/30/2020	12/31/2020	3/31/2021	6/30/2021	9/30/2021	12/31/2021	3/31/2022	6/30/2022	9/30/2022	12/31/2022	3/31/2023
3			Q121	Q221	Q321	Q421	Q122	Q222	Q322	Q422	Q123	Q223	Q323	Q423
4		Japan							163365				169414
5		Americas							120765				161880
6		China							79996				91537
7		EMEA							44339				52524
8		Asia/LatAm							36589				37817
9		OTC							18715				18710
10		API							101554				14316
11
12		Lenvima US					24400	26900	31300	33800	38500	41700	43000
13		Humira JP							38700				37500
14		Lenvima CH							28400				27400
15		Dayvigo JP							8600				18100
16		Fycompa US							10800				14100
17		Methycobal CH							10000				12000
18		Halaven US							10400				11000
19		Lenvima JP							7700				10600
20		Methycobal JP							8200				8200
21		Halaven JP							6300				6500
22		Elental JP							5200				5500
23		Jyseleca JP							900				5300
24		Goofice JP							4600				5100
25		Fycompa JP							4100				4700
26		Pariet JP							5500				4500
27		Movicol JP							3700				4400
28		Banzel US							6200				3700
29		Dayvigo US							2700				3600
30		Aricept JP							5600				3400
31
32		Revenue					198900	163500	202925	190900	184300	174400	187497
33		COGS							124093				139272
34		Gross Profit							78832				48225
35		SG&A							256162				272970
36		R&D							123278				121403
37		Operating Expenses							379440				394373
38		Operating Income							-300608				-346148
39		Interest Income							13242				5038
40		Pretax Income							-287366				-341110
41		Taxes							15599				0
42		Net Income							-302965				-341110
43		EPS											-1188.5365853658536
44		S/O											287